Abortion pill maker alerts doctors to five deaths

Key points
- Five women who took the abortion pill RU-486 have died from bacterial infections since its U.S. introduction nearly five years ago, the manufacturer reported on Monday.
- "No causal relationship between these events" has been established with the drug, also known as Mifeprex or mifepristone, maker Danco Laboratories LLC said.
- "Childbirth, menstruation and abortion, whether spontaneous, surgical or medical, all create conditions that can result in serious and sometimes fatal infection, and there is no evidence that Mifeprex and misoprostol present a special risk of infection," the company said in a statement.
- Misoprostol is a drug that women must take two days after Mifeprex to complete the abortion.
Five women who took the abortion pill RU-486 have died from bacterial infections since its U.S. introduction nearly five years ago, the manufacturer reported on Monday.
"No causal relationship between these events" has been established with the drug, also known as Mifeprex or mifepristone, maker Danco Laboratories LLC said.
"Childbirth, menstruation and abortion, whether spontaneous, surgical or medical, all create conditions that can result in serious and sometimes fatal infection, and there is no evidence that Mifeprex and misoprostol present a special risk of infection," the company said in a statement.
Misoprostol is a drug that women must take two days after Mifeprex to complete the abortion.
Danco said it was sending a letter to alert physicians about the cases and updating warning information on the drug's label.
Mifeprex already carries a warning about the possibility that women who take the drug could experience serious and sometimes fatal infections. The company is updating the label to give physicians more information to help them spot the problem, Danco spokeswoman Cynthia Summers said.
"With these very rare infections, we want people to be able to recognize them early," she said.
RU-486 is approved for terminating a pregnancy of 49 days or less. Abortion opponents fought vigorously to keep it off the U.S. market and have asked the FDA to revoke the approval.
More than 460,000 U.S. women have taken Mifeprex since September 2000, Danco said.
One of the deaths occurred during a clinical trial in Canada in 2001, the company said. The other four were reported in California. Two of the California deaths were reported in late 2003, one in early 2004 and one in mid-2005.
Three of the cases involved a rare bacterium known as Clostridium sordellii, Danco's statement said.
Women who take Mifeprex and misoprostol should contact a doctor or visit an emergency room immediately if they experience abdominal pain or discomfort or general malaise more than 24 hours after taking misoprostol, Danco said.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Addiction →
NewsCell harm seen in lab tests of e-cigarettes
Adding to growing evidence on the possible health risks of electronic cigarettes, a lab team at the Veterans Affairs San Diego Healthcare System tested two products and found they damaged cells in ways that could lead…
30 December 2015
NewsHow graphic photos on cigarette packs help smokers consider quitting
A new study is the first to provide real-world evidence of the effectiveness of smoking warning labels that include graphic photos of the damage caused by regular tobacco use. Researchers found that smokers who saw…
22 December 2015
NewsUniversity of Toronto scientists uncover how opioids cause dangerous breathing problems
University of Toronto researchers on a quest to make opioid drugs less lethal have discovered a window of opportunity: a tiny channel in the brain where opioids interfere with the breathing mechanism. They found that…
